K. Miyamoto

Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of N(ɛ)-carboxymethyl lysine.

T. Saruta, H. Itoh, M. Tabata, 2010, Journal of diabetes and its complications.

Efficacy of ezetimibe is associated with gender and baseline lipid levels in patients with type 2 diabetes.

Y. Terauchi, S. Morita, H. Shigematsu, 2012, Journal of atherosclerosis and thrombosis.

Secretion of GIP in responders to acarbose in obese Type 2(NIDDM) patients.

T. Saruta, I. Takei, M. Tokui, 2001, Journal of diabetes and its complications.

Cilostazol, a phosphodiesterase inhibitor for the treatment of diabetic neuropathy

T. Saruta, I. Takei, M. Tokui, 1997 .